You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA damage response DDR

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Breast Cancer, Brain Metastases, Adult Trial in Birmingham, Chapel Hill, Durham (Olaparib, Stereotactic Radiosurgery,

Not yet recruiting
  • Breast Cancer
  • Brain Metastases, Adult
  • (no location specified)
Oct 25, 2021

Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

Withdrawn
  • Advanced Solid Tumor
  • Breast Cancer
  • (no location specified)
Jun 24, 2021

Bile Duct Cancer, Chemo Effect Trial in Seoul (AZD6738, Durvalumab, Olaparib)

Recruiting
  • Bile Duct Cancer
  • Chemotherapy Effect
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)

Unknown status
  • DDR Gene Mutation
  • Metastatic Solid Tumor
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

    Recruiting
    • Metastatic or Locally Advanced Unresectable Solid Tumors
    • Houston, Texas
    • +4 more
    Jul 7, 2022

    Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

    Not yet recruiting
    • Breast Cancer
    • Marseille, France
      Institut Paoli Calmettes
    Aug 9, 2023

    Head and Neck Squamous Cell Carcinoma Trial in France, Taiwan, United States (Ceralasertib, Olaparib)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Pittsburgh, Pennsylvania
    • +3 more
    Aug 9, 2021

    Advanced Solid Tumours Trial in France, Spain, United States (Ceralasertib)

    Recruiting
    • Advanced Solid Tumours
    • Tucson, Arizona
    • +31 more
    Jan 13, 2023

    Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

    Recruiting
    • Non Small Cell Lung Cancer
    • Radiotherapy
    • +5 more
    • Newcastle Upon Tyne, United Kingdom
      Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
    Sep 20, 2022

    Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal

    Recruiting
    • Prostate Cancer
    • +3 more
    • Stereotactic Body Radiotherapy
    • Edinburgh, Mid Lothian, United Kingdom
      Edinburgh Cancer Centre, Western General Hospital
    Apr 5, 2022

    Breast Tumor Trial in United Kingdom (AZD6738, Olaparib, Durvalumab)

    Recruiting
    • Breast Neoplasm
    • Bournemouth, Dorset, United Kingdom
    • +8 more
    Feb 19, 2020

    Soft Tissue Sarcoma Adult Trial in Amsterdam (AZD1390 + radiotherapy, AZD7648 + radiotherapy)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • AZD1390 + radiotherapy
    • AZD7648 + radiotherapy
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Aug 29, 2022

    Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

    Recruiting
    • Metastatic Pancreatic Cancer
    • Barcelona, Spain
    • +2 more
    Dec 29, 2022

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +5 more
    • (no location specified)
    Apr 8, 2023

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

    Recruiting
    • Endometrial Serous Adenocarcinoma
    • +2 more
    • Biopsy
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Feb 2, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Metastatic Malignant Solid Neoplasm
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 18, 2023

    Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

    Recruiting
    • Lung Cancer
    • Olaparib+Bevacizumab to SCLC patients
    • Seoul, Gangnam-gu, Korea, Republic of
    • +3 more
    Nov 9, 2022

    Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • New Haven, Connecticut
    • +6 more
    Oct 10, 2022